Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Drug Store accounting for % of the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Aspirin segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) include Roche (Genentech), Amgen, B-MS, Merck, and Pfizer, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Aspirin
Ibuprofen
Naproxen
Celecoxib
Others
Market segment by Application, can be divided into
Drug Store
Hospital Pharmacies
Online
Market segment by players, this report covers
Roche (Genentech)
Amgen
B-MS
Merck
Pfizer
Novartis
Eli Lilly and Company
Johnson & Johnson
GSK
Sanofi
Boehringer Ingelheim
Zhejiang Jiuzhou Pharmaceutical
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), with revenue, gross margin and global market share of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) from 2019 to 2022.
Chapter 3, the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
1.2 Classification of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Type
1.2.1 Overview: Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type in 2021
1.2.3 Aspirin
1.2.4 Ibuprofen
1.2.5 Naproxen
1.2.6 Celecoxib
1.2.7 Others
1.3 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market by Application
1.3.1 Overview: Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Drug Store
1.3.3 Hospital Pharmacies
1.3.4 Online
1.4 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size & Forecast
1.5 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast by Region
1.5.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region, (2017-2022)
1.5.3 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Prospect (2017-2028)
1.5.4 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Prospect (2017-2028)
1.5.6 South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers
1.6.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints
1.6.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Trends Analysis
2 Company Profiles
2.1 Roche (Genentech)
2.1.1 Roche (Genentech) Details
2.1.2 Roche (Genentech) Major Business
2.1.3 Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
2.1.4 Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Roche (Genentech) Recent Developments and Future Plans
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
2.2.4 Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Amgen Recent Developments and Future Plans
2.3 B-MS
2.3.1 B-MS Details
2.3.2 B-MS Major Business
2.3.3 B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
2.3.4 B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 B-MS Recent Developments and Future Plans
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
2.4.4 Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Merck Recent Developments and Future Plans
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
2.5.4 Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Pfizer Recent Developments and Future Plans
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
2.6.4 Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Novartis Recent Developments and Future Plans
2.7 Eli Lilly and Company
2.7.1 Eli Lilly and Company Details
2.7.2 Eli Lilly and Company Major Business
2.7.3 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
2.7.4 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Eli Lilly and Company Recent Developments and Future Plans
2.8 Johnson & Johnson
2.8.1 Johnson & Johnson Details
2.8.2 Johnson & Johnson Major Business
2.8.3 Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
2.8.4 Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Johnson & Johnson Recent Developments and Future Plans
2.9 GSK
2.9.1 GSK Details
2.9.2 GSK Major Business
2.9.3 GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
2.9.4 GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 GSK Recent Developments and Future Plans
2.10 Sanofi
2.10.1 Sanofi Details
2.10.2 Sanofi Major Business
2.10.3 Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
2.10.4 Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Sanofi Recent Developments and Future Plans
2.11 Boehringer Ingelheim
2.11.1 Boehringer Ingelheim Details
2.11.2 Boehringer Ingelheim Major Business
2.11.3 Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
2.11.4 Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Boehringer Ingelheim Recent Developments and Future Plans
2.12 Zhejiang Jiuzhou Pharmaceutical
2.12.1 Zhejiang Jiuzhou Pharmaceutical Details
2.12.2 Zhejiang Jiuzhou Pharmaceutical Major Business
2.12.3 Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
2.12.4 Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Zhejiang Jiuzhou Pharmaceutical Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players Market Share in 2021
3.2.2 Top 10 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players Head Office, Products and Services Provided
3.4 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Mergers & Acquisitions
3.5 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Market Share by Type (2017-2022)
4.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application (2017-2022)
5.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2017-2028)
6.2 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2017-2028)
6.3 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
6.3.1 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2017-2028)
6.3.2 United States Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2017-2028)
6.3.3 Canada Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2017-2028)
6.3.4 Mexico Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2017-2028)
7.2 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2017-2028)
7.3 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
7.3.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2017-2028)
7.3.2 Germany Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2017-2028)
7.3.3 France Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2017-2028)
7.3.5 Russia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2017-2028)
7.3.6 Italy Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2017-2028)
8.2 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2017-2028)
8.3 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region
8.3.1 Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Region (2017-2028)
8.3.2 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2017-2028)
8.3.3 Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2017-2028)
8.3.4 South Korea Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2017-2028)
8.3.5 India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2017-2028)
8.3.7 Australia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2017-2028)
9.2 South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2017-2028)
9.3 South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
9.3.1 South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2017-2028)
9.3.2 Brazil Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2017-2028)
9.3.3 Argentina Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2017-2028)
10.2 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2017-2028)
10.3 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
10.3.1 Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2017-2028)
10.3.2 Turkey Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2017-2028)
10.3.4 UAE Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million) by Region (2017-2022)
Table 5. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Region (2023-2028)
Table 6. Roche (Genentech) Corporate Information, Head Office, and Major Competitors
Table 7. Roche (Genentech) Major Business
Table 8. Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
Table 9. Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Amgen Corporate Information, Head Office, and Major Competitors
Table 11. Amgen Major Business
Table 12. Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
Table 13. Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. B-MS Corporate Information, Head Office, and Major Competitors
Table 15. B-MS Major Business
Table 16. B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
Table 17. B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Merck Corporate Information, Head Office, and Major Competitors
Table 19. Merck Major Business
Table 20. Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
Table 21. Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Pfizer Corporate Information, Head Office, and Major Competitors
Table 23. Pfizer Major Business
Table 24. Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
Table 25. Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Novartis Corporate Information, Head Office, and Major Competitors
Table 27. Novartis Major Business
Table 28. Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
Table 29. Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Eli Lilly and Company Corporate Information, Head Office, and Major Competitors
Table 31. Eli Lilly and Company Major Business
Table 32. Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
Table 33. Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 35. Johnson & Johnson Major Business
Table 36. Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
Table 37. Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. GSK Corporate Information, Head Office, and Major Competitors
Table 39. GSK Major Business
Table 40. GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
Table 41. GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Sanofi Corporate Information, Head Office, and Major Competitors
Table 43. Sanofi Major Business
Table 44. Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
Table 45. Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors
Table 47. Boehringer Ingelheim Major Business
Table 48. Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
Table 49. Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Zhejiang Jiuzhou Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 51. Zhejiang Jiuzhou Pharmaceutical Major Business
Table 52. Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
Table 53. Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 55. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 56. Breakdown of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players Head Office, Products and Services Provided
Table 58. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Mergers & Acquisitions in the Past Five Years
Table 59. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) New Entrants and Expansion Plans
Table 60. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million) by Type (2017-2022)
Table 61. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Type (2017-2022)
Table 62. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Forecast by Type (2023-2028)
Table 63. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2017-2022)
Table 64. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Forecast by Application (2023-2028)
Table 65. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2017-2022) & (USD Million)
Table 66. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2023-2028) & (USD Million)
Table 67. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2017-2022) & (USD Million)
Table 68. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2023-2028) & (USD Million)
Table 69. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2017-2022) & (USD Million)
Table 70. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2023-2028) & (USD Million)
Table 71. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2017-2022) & (USD Million)
Table 72. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2023-2028) & (USD Million)
Table 73. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2017-2022) & (USD Million)
Table 74. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2023-2028) & (USD Million)
Table 75. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2017-2022) & (USD Million)
Table 76. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2023-2028) & (USD Million)
Table 77. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2017-2022) & (USD Million)
Table 78. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2023-2028) & (USD Million)
Table 79. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2017-2022) & (USD Million)
Table 80. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2023-2028) & (USD Million)
Table 81. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Region (2017-2022) & (USD Million)
Table 82. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Region (2023-2028) & (USD Million)
Table 83. South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2017-2022) & (USD Million)
Table 84. South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2023-2028) & (USD Million)
Table 85. South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2017-2022) & (USD Million)
Table 86. South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2023-2028) & (USD Million)
Table 87. South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2017-2022) & (USD Million)
Table 88. South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2023-2028) & (USD Million)
Table 89. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2017-2022) & (USD Million)
Table 90. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type (2023-2028) & (USD Million)
Table 91. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2017-2022) & (USD Million)
Table 92. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2023-2028) & (USD Million)
Table 93. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2017-2022) & (USD Million)
Table 94. Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Picture
Figure 2. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type in 2021
Figure 3. Aspirin
Figure 4. Ibuprofen
Figure 5. Naproxen
Figure 6. Celecoxib
Figure 7. Others
Figure 8. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application in 2021
Figure 9. Drug Store Picture
Figure 10. Hospital Pharmacies Picture
Figure 11. Online Picture
Figure 12. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 13. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Region (2017-2028)
Figure 15. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Region in 2021
Figure 16. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers
Figure 22. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints
Figure 23. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Trends
Figure 24. Roche (Genentech) Recent Developments and Future Plans
Figure 25. Amgen Recent Developments and Future Plans
Figure 26. B-MS Recent Developments and Future Plans
Figure 27. Merck Recent Developments and Future Plans
Figure 28. Pfizer Recent Developments and Future Plans
Figure 29. Novartis Recent Developments and Future Plans
Figure 30. Eli Lilly and Company Recent Developments and Future Plans
Figure 31. Johnson & Johnson Recent Developments and Future Plans
Figure 32. GSK Recent Developments and Future Plans
Figure 33. Sanofi Recent Developments and Future Plans
Figure 34. Boehringer Ingelheim Recent Developments and Future Plans
Figure 35. Zhejiang Jiuzhou Pharmaceutical Recent Developments and Future Plans
Figure 36. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Players in 2021
Figure 37. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 38. Global Top 3 Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share in 2021
Figure 39. Global Top 10 Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share in 2021
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 41. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Type in 2021
Figure 42. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share Forecast by Type (2023-2028)
Figure 43. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Application in 2021
Figure 44. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share Forecast by Application (2023-2028)
Figure 45. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Type (2017-2028)
Figure 46. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application (2017-2028)
Figure 47. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Country (2017-2028)
Figure 48. United States Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Canada Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Mexico Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Type (2017-2028)
Figure 52. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application (2017-2028)
Figure 53. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Country (2017-2028)
Figure 54. Germany Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. France Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. United Kingdom Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Russia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Italy Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Type (2017-2028)
Figure 60. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application (2017-2028)
Figure 61. Asia-Pacific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Region (2017-2028)
Figure 62. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South Korea Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Australia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Type (2017-2028)
Figure 69. South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application (2017-2028)
Figure 70. South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Country (2017-2028)
Figure 71. Brazil Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Argentina Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Type (2017-2028)
Figure 74. Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Application (2017-2028)
Figure 75. Middle East and Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Country (2017-2028)
Figure 76. Turkey Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. UAE Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source
